ConductScience.org, home

Paper21079427

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.

Lester R and 6 others. AIDS, 2010. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. Papers, record 21079427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
PubMed
Journal
AIDS
PubMed
Year
2010
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.85
iCite
Revised in PubMed
2022-04-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lester RRebecca
2Hamilton RRobin
3Charalambous SSalome
4Dwadwa TThobeka
5Chandler CClare
6Churchyard GJGavin J
7Grant ADAlison D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related Opportunistic InfectionsMajor topic
Antitubercular AgentsMajor topic
Delivery of Health CareMajor topic
HIV InfectionsMajor topic
IsoniazidMajor topic
TuberculosisMajor topic
Adult
Female
Humans
Interviews as Topic
Male
Middle Aged
Qualitative Research
South Africa

Source PubMed

Download CSV of topics

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
42880810Preferences for treatment for latent tuberculosis infection in primary care among people in the USA at increased risk of tuberculosis: a pilot survey.BMJ Open2026https://conductscience.org/library/papers/42880810PubMed
42746401Implementation insights into bridging the gaps in isoniazid preventive therapy uptake in adults with HIV.IJTLD Open2026https://conductscience.org/library/papers/42746401PubMed
42721162Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda - A discrete choice experiment.PLOS Glob Public Health2026https://conductscience.org/library/papers/42721162PubMed
42646802Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers' Perspectives.Trop Med Infect Dis2026https://conductscience.org/library/papers/42646802PubMed
41150373Evaluation of Tuberculosis Preventive Treatment Uptake Among People Living with HIV in PEPFAR-Supported Facilities in Zimbabwe.Trop Med Infect Dis2025https://conductscience.org/library/papers/41150373PubMed
41005953'And the stick to fight TB is TPT': nurse-identified barriers and facilitators of tuberculosis preventive therapy implementation in rural South Africa.BMJ Open Respir Res2025https://conductscience.org/library/papers/41005953PubMed
40657267TB elimination in Southern Africa: overview and critical reflection.IJTLD Open2025https://conductscience.org/library/papers/40657267PubMed
40028639Choice-architecture TB preventive therapy prescribing for HIV patients in Mozambique.Public Health Action2025https://conductscience.org/library/papers/40028639PubMed
39733063Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.Drugs2025https://conductscience.org/library/papers/39733063PubMed
39587885Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.J Int AIDS Soc2024https://conductscience.org/library/papers/39587885PubMed
39036871
Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With HIV in the North West Province of South Africa (the Teko Study): A Cluster Randomized Trial.
Clin Infect Dis2024https://conductscience.org/library/papers/39036871PubMed
38966799Loss to follow-up among people living with HIV on tuberculosis preventive treatment at four regional referral hospitals, Uganda, 2019-2021.J Clin Tuberc Other Mycobact Dis2024https://conductscience.org/library/papers/38966799PubMed
38178173Health care providers acceptance of default prescribing of TB preventive treatment for people living with HIV in Malawi: a qualitative study.BMC Health Serv Res2024https://conductscience.org/library/papers/38178173PubMed
37167225Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: A qualitative study.PLoS One2023https://conductscience.org/library/papers/37167225PubMed
37046895Knowledge and Perceptions of Healthcare Workers about the Implementation of the Universal Test and Treat Guideline in Under-Resourced, High-HIV Prevalence Rural Settings.Healthcare (Basel)2023https://conductscience.org/library/papers/37046895PubMed
37012895Strengthening HIV and HIV co-morbidity care in low- and middle-income countries: insights from behavioural economics to improve healthcare worker behaviour.J Int AIDS Soc2023https://conductscience.org/library/papers/37012895PubMed
36962910Community-based referral for tuberculosis preventive therapy is effective for treatment completion.PLOS Glob Public Health2022https://conductscience.org/library/papers/36962910PubMed
36561901Reasons for poor uptake of TB preventive therapy in South Africa.Public Health Action2022https://conductscience.org/library/papers/36561901PubMed
36434517Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania.BMC Infect Dis2022https://conductscience.org/library/papers/36434517PubMed
36181120Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study.Medicine (Baltimore)2022https://conductscience.org/library/papers/36181120PubMed

See all 68 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21079427

GET https://conductscience.org/api/papers/v1/21079427/cited_by?page=2